Evidence map›Paper›PMID 36376408›Full record

ArticleScientific reports2022

Retinal functional ultrasound imaging (rfUS) for assessing neurovascular alterations: a pilot study on a rat model of dementia.

Clementine Morisset, Alexandre Dizeux, Benoit Larrat, Erwan Selingue, Herve Boutin, Serge Picaud, Jose-Alain Sahel, Nathalie Ialy-Radio, Sophie Pezet, Mickael Tanter and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A flexible photoacoustic retinal prosthesis.bioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Clementine MorissetInstitute Physics for Medicine Paris, INSERM U1273, ESPCI PSL Paris, CNRS UMR 8631, PSL Research University, Paris, France.
Alexandre DizeuxInstitute Physics for Medicine Paris, INSERM U1273, ESPCI PSL Paris, CNRS UMR 8631, PSL Research University, Paris, France.
Benoit LarratNeuroSpin, Institut Des Sciences du Vivant Frédéric Joliot, Commissariat À L'Energie Atomique Et Aux Energies Alternatives (CEA), CNRS, Université Paris-Saclay, 91191, Gif-Sur-Yvette, France.
Erwan SelingueNeuroSpin, Institut Des Sciences du Vivant Frédéric Joliot, Commissariat À L'Energie Atomique Et Aux Energies Alternatives (CEA), CNRS, Université Paris-Saclay, 91191, Gif-Sur-Yvette, France.
Herve BoutinFaculty of Biology, Medicine and Health, School of Biological Sciences Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, M13 9PL, UK.
Serge PicaudInstitut de La Vision, Sorbonne Université, INSERM, CNRS, 17 Rue Moreau, 75012, Paris, France.
Jose-Alain SahelInstitut de La Vision, Sorbonne Université, INSERM, CNRS, 17 Rue Moreau, 75012, Paris, France.
Nathalie Ialy-RadioInstitute Physics for Medicine Paris, INSERM U1273, ESPCI PSL Paris, CNRS UMR 8631, PSL Research University, Paris, France.
Sophie PezetInstitute Physics for Medicine Paris, INSERM U1273, ESPCI PSL Paris, CNRS UMR 8631, PSL Research University, Paris, France.
Mickael TanterInstitute Physics for Medicine Paris, INSERM U1273, ESPCI PSL Paris, CNRS UMR 8631, PSL Research University, Paris, France.
Thomas DeffieuxInstitute Physics for Medicine Paris, INSERM U1273, ESPCI PSL Paris, CNRS UMR 8631, PSL Research University, Paris, France. thomas.deffieux@espci.fr.
Centre National de la Recherche Scientifique · FRInserm · FRUniversité Paris Sciences et Lettres · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRUniversity of Manchester · GB

Funding

Agence Nationale de la Recherche ANR-10-LABX-0065European Research Council #610110
6 · The paper itself

Abstract

Fifty million people worldwide are affected by dementia, a heterogeneous neurodegenerative condition encompassing diseases such as Alzheimer's, vascular dementia, and Parkinson's. For them, cognitive decline is often the first marker of the pathology after irreversible brain damage has already occurred. Researchers now believe that structural and functional alterations of the brain vasculature could be early precursors of the diseases and are looking at how functional imaging could provide an early diagnosis years before irreversible clinical symptoms. In this preclinical pilot study, we proposed using functional ultrasound (fUS) on the retina to assess neurovascular alterations non-invasively, bypassing the skull limitation. We demonstrated for the first time the use of functional ultrasound in the retina and applied it to characterize the retinal hemodynamic response function in vivo in rats following a visual stimulus. We then demonstrated that retinal fUS could measure robust neurovascular coupling alterations between wild-type rats and TgF344-AD rat models of Alzheimer's disease. We observed an average relative increase in blood volume of 21% in the WT versus 37% for the TG group (p = 0.019). As a portable, non-invasive and inexpensive technique, rfUS is a promising functional screening tool in clinics for dementia years before symptoms.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAnimalsPilot ProjectsRatsRetinaUltrasonography

Identifiers

PMID36376408
PMCPMC9663720
OpenAlexW4308964429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.